Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
1.345
-0.015 (-1.10%)
Nov 4, 2026, 12:02 PM EST - Market open
Aptevo Therapeutics Market Cap
Aptevo Therapeutics has a market cap or net worth of $3.58 million as of November 4, 2026. It is the 46,081st most valuable company in the world and the 6,127th biggest in the United States. Its market cap has decreased by 25.83% in one year.
Market Cap
3.58M
Enterprise Value
-2.00M
1-Year Change
-25.83%
Global Rank
Country Rank
#6,127 United States
Category
ChartMarket Cap Chart
Since August 1, 2016, Aptevo Therapeutics's market cap has decreased from $47.42M to $3.58M, a decrease of -92.44%. That is a compound annual growth rate of -22.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 3.58M | -59.39% |
| Dec 31, 2025 | 8.83M | 309.61% |
| Dec 31, 2024 | 2.16M | -36.51% |
| Dec 29, 2023 | 3.39M | -68.79% |
| Dec 30, 2022 | 10.88M | -70.52% |
| Dec 31, 2021 | 36.90M | -75.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NuCana | 4.31M |
| Cadrenal Therapeutics | 4.03M |
| Liminatus Pharma | 3.75M |
| PharmaCyte Biotech | 3.65M |
| 60 Degrees Pharmaceuticals | 3.55M |
| Dermata Therapeutics | 3.41M |
| GRI Bio | 3.37M |
| KALA BIO | 3.35M |